Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Predicting clinical outcomes in the Machine Learning era: The Piacenza score a purely data driven approach for mortality prediction in COVID-19 Pneumonia

Geza Halasz, Michela Sperti, Matteo Villani, Umberto Michelucci, Piergiuseppe Agostoni, Andrea Biagi, Luca Rossi, Andrea Botti, Chiara Mari, Marco Maccarini, Filippo Pura, Loris Roveda, Alessia Nardecchia, Emanuele Mottola, Massimo Nolli, Elisabetta Salvioni, Massimo Mapelli, Marco Agostino Deriu, Dario Piga, Massimo Piepoli
doi: https://doi.org/10.1101/2021.03.16.21253752
Geza Halasz
1Cardiology Department Guglielmo Da Saliceto Hospital; Piacenza, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: geza.halasz@gmail.com
Michela Sperti
2PolitoBIOMed Lab, Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Torino, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matteo Villani
3Anesthesiology and ICU department Guglielmo da Saliceto Hospital; Piacenza, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Umberto Michelucci
4TOELT LLC, Birchlenstr. 25, 8600 Dübendorf, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Piergiuseppe Agostoni
5Department of Clinical Sciences and Community Health, Centro Cardiologico Monzino, IRCCS Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Biagi
1Cardiology Department Guglielmo Da Saliceto Hospital; Piacenza, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luca Rossi
1Cardiology Department Guglielmo Da Saliceto Hospital; Piacenza, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Botti
6Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chiara Mari
6Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marco Maccarini
7Istituto Dalle Molle di studi sulI’Intelligenza Artificiale IDSIA - USI/SUPSI, Via la Santa 1, CH-6962 Lugano-Viganello, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Filippo Pura
7Istituto Dalle Molle di studi sulI’Intelligenza Artificiale IDSIA - USI/SUPSI, Via la Santa 1, CH-6962 Lugano-Viganello, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Loris Roveda
7Istituto Dalle Molle di studi sulI’Intelligenza Artificiale IDSIA - USI/SUPSI, Via la Santa 1, CH-6962 Lugano-Viganello, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alessia Nardecchia
8IIS “A.Cesaris”, viale Cadorna, Casalpusterlengo, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emanuele Mottola
97HC srl, Rome Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Massimo Nolli
3Anesthesiology and ICU department Guglielmo da Saliceto Hospital; Piacenza, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elisabetta Salvioni
5Department of Clinical Sciences and Community Health, Centro Cardiologico Monzino, IRCCS Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Massimo Mapelli
5Department of Clinical Sciences and Community Health, Centro Cardiologico Monzino, IRCCS Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marco Agostino Deriu
2PolitoBIOMed Lab, Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Torino, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dario Piga
7Istituto Dalle Molle di studi sulI’Intelligenza Artificiale IDSIA - USI/SUPSI, Via la Santa 1, CH-6962 Lugano-Viganello, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Massimo Piepoli
1Cardiology Department Guglielmo Da Saliceto Hospital; Piacenza, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Several models have been developed to predict mortality in patients with COVID-19 pneumonia, but only few have demonstrated enough discriminatory capacity. Machine-learning(ML) algorithms represent a novel approach for data-driven prediction of clinical outcomes with advantages over statistical modelling. We developed the Piacenza score, a ML-based score, to predict 30-day mortality in patients with COVID-19 pneumonia.

Methods 852 patients (mean age 70years, 70%males) were enrolled from February to November 2020. The dataset was randomly splitted into derivation and test. The Piacenza score was obtained through the Naïve Bayes classifier and externally validated on 86 patients. Using a forward-search algorithm the following six features were identified: age; mean corpuscular haemoglobin concentration; PaO2 /FiO2 ratio; temperature; previous stroke; gender. In case one or more of the features are not available for a patient, the model can be re-trained using only the provided features.

We also compared the Piacenza score with the 4C score and with a Naïve Bayes algorithm with 14 variables chosen a-priori.

Results The Piacenza score showed an AUC of 0.78(95% CI 0.74-0.84, Brier-score 0.19) in the internal validation cohort and 0.79(95% CI 0.68-0.89, Brier-score 0.16) in the external validation cohort showing a comparable accuracy respect to the 4C score and to the Naïve Bayes model with a-priori chosen features, which achieved an AUC of 0.78(95% CI 0.73-0.83, Brier-score 0.26) and 0.80(95% CI 0.75-0.86, Brier-score 0.17) respectively.

Conclusion A personalized ML-based score with a purely data driven features selection is feasible and effective to predict mortality in patients with COVID-19 pneumonia.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

None

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

AUSL Piacenza ethics committee

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

If request, we agree to publicly share the study data and analysis source code.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted March 20, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Predicting clinical outcomes in the Machine Learning era: The Piacenza score a purely data driven approach for mortality prediction in COVID-19 Pneumonia
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Predicting clinical outcomes in the Machine Learning era: The Piacenza score a purely data driven approach for mortality prediction in COVID-19 Pneumonia
Geza Halasz, Michela Sperti, Matteo Villani, Umberto Michelucci, Piergiuseppe Agostoni, Andrea Biagi, Luca Rossi, Andrea Botti, Chiara Mari, Marco Maccarini, Filippo Pura, Loris Roveda, Alessia Nardecchia, Emanuele Mottola, Massimo Nolli, Elisabetta Salvioni, Massimo Mapelli, Marco Agostino Deriu, Dario Piga, Massimo Piepoli
medRxiv 2021.03.16.21253752; doi: https://doi.org/10.1101/2021.03.16.21253752
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Predicting clinical outcomes in the Machine Learning era: The Piacenza score a purely data driven approach for mortality prediction in COVID-19 Pneumonia
Geza Halasz, Michela Sperti, Matteo Villani, Umberto Michelucci, Piergiuseppe Agostoni, Andrea Biagi, Luca Rossi, Andrea Botti, Chiara Mari, Marco Maccarini, Filippo Pura, Loris Roveda, Alessia Nardecchia, Emanuele Mottola, Massimo Nolli, Elisabetta Salvioni, Massimo Mapelli, Marco Agostino Deriu, Dario Piga, Massimo Piepoli
medRxiv 2021.03.16.21253752; doi: https://doi.org/10.1101/2021.03.16.21253752

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (76)
  • Allergy and Immunology (202)
  • Anesthesia (55)
  • Cardiovascular Medicine (497)
  • Dentistry and Oral Medicine (91)
  • Dermatology (57)
  • Emergency Medicine (170)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (220)
  • Epidemiology (5776)
  • Forensic Medicine (3)
  • Gastroenterology (223)
  • Genetic and Genomic Medicine (889)
  • Geriatric Medicine (89)
  • Health Economics (235)
  • Health Informatics (778)
  • Health Policy (401)
  • Health Systems and Quality Improvement (259)
  • Hematology (108)
  • HIV/AIDS (188)
  • Infectious Diseases (except HIV/AIDS) (6612)
  • Intensive Care and Critical Care Medicine (398)
  • Medical Education (120)
  • Medical Ethics (29)
  • Nephrology (94)
  • Neurology (864)
  • Nursing (46)
  • Nutrition (145)
  • Obstetrics and Gynecology (166)
  • Occupational and Environmental Health (268)
  • Oncology (521)
  • Ophthalmology (169)
  • Orthopedics (44)
  • Otolaryngology (108)
  • Pain Medicine (49)
  • Palliative Medicine (22)
  • Pathology (150)
  • Pediatrics (258)
  • Pharmacology and Therapeutics (147)
  • Primary Care Research (116)
  • Psychiatry and Clinical Psychology (998)
  • Public and Global Health (2273)
  • Radiology and Imaging (382)
  • Rehabilitation Medicine and Physical Therapy (176)
  • Respiratory Medicine (315)
  • Rheumatology (111)
  • Sexual and Reproductive Health (85)
  • Sports Medicine (83)
  • Surgery (118)
  • Toxicology (25)
  • Transplantation (35)
  • Urology (42)